13 January 2026 : Clinical Research
Comparative Outcomes of Tricuspid-Dedicated Versus Non-Dedicated Devices in Transcatheter Tricuspid Edge-to-Edge Repair
Adam RdzanekDOI: 10.12659/MSM.950175
Med Sci Monit 2026; 32:e950175
Table 2 Echocardiographic characterization of included patients.
| Parameter | OverallN=44 | Non-dedicated (MitraClip) N=22 | Dedicated (TriClip or PASCAL) N=22 | P value |
|---|---|---|---|---|
| Baseline MR | ||||
| – No/trace | 4 (9.1%) | 0 (0.0%) | 4 (18.2%) | |
| – Mild | 9 (20.5%) | 0 (0.0%) | 9 (40.9%) | |
| – Moderate | 15 (34.1%) | 6 (27.3%) | 9 (40.9%) | |
| – Severe | 16 (36.4%) | 16 (72.7%) | 0 (0.0%) | |
| Baseline TR | 0.16 | |||
| – Moderate | 2 (4.5%) | 2 (9.1%) | 0 (0.0%) | |
| – Severe | 18 (40.9%) | 10 (45.5%) | 7 (31.8%) | |
| – Massive | 14 (31.8%) | 4 (18.2%) | 10 (45.5%) | |
| – Torrential | 10 (22.7%) | 6 (27.3%) | 5 (27.3%) | |
| LVDd | 5.0 (2.0) | 5.9 (1.1) | 4.6 (1.3) | |
| IVSd | 1.1 (0.3) | 1.1 (0.4) | 1.0 (0.3) | 0.18 |
| PWTd | 1.0 (0.1) | 0.9 (0.3) | 0.9 (0.1) | 0.85 |
| RV | 3.6 (0.7) | 3.7 (0.8) | 3.5 (0.5) | 0.37 |
| Ao | 3.4 (0.5) | 3.5 (0.4) | 3.3 (0.5) | 0.33 |
| LAA | 37.0 (17.0) | 39.3 (14.6) | 39.6 (9.1) | 0.97 |
| RAA | 31.6 (11.0) | 35.0 (12.0) | 34.3 (10.3) | 0.78 |
| LVEF | 46.0 (31.0) | 33.5 (24.0) | 58.0 (16.0) | |
| TAPSE | 16.4 (3.5) | 16.2 (3.9) | 16.6 (3.2) | 0.75 |
| SPAP | 47.0 (12.2) | 47.2 (11.1) | 46.9 (13.2) | 0.95 |
| TAPSE/SPAP | 0.36 (0.19) | 0.36 (0.13) | 0.37 (0.17) | 0.97 |
| Ao – aorta diameter; LAA – left-atrial area; LVDd – left-ventricular diameter in diastole; LVEF – left-ventricular ejection fraction; IVSd – intraventricular septum in diastole; MR – mitral regurgitation; PWTd – posterior wall thickness in diastole; RAA – right-atrial area; RV – right ventricle; SPAP – systolic pulmonary artery pressure; TAPSE – tricuspid annular plane systolic excursion; TAPSE/SPAP – tricuspid annular plane systolic excursion to systolic pulmonary artery pressure ratio; TR – tricuspid regurgitation. | ||||






